REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Axon Pharma Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Axon Pharma Sas Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Axon Pharma Sas is based in Colombia. The head office is in Bogota D.C.. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on March 23, 2006. 136 (2024) employees currently work for Axon Pharma Sas. There was a net sales revenue increase of 56.36% reported in Axon Pharma Sas’s latest financial highlights for 2023. Its’ total assets recorded a growth of 91.09%. Axon Pharma Sas’s net profit margin decreased by 2% in 2023.

Headquarters
Calle 97 11 B 17 Oficina 401
Bogota D.C.; Bogota D.C; Postal Code: 0809

Contact Details: Purchase the Axon Pharma Sas report to view the information.

Basic Information
Total Employees:
Purchase the Axon Pharma Sas report to view the information.
Outstanding Shares:
Purchase the Axon Pharma Sas report to view the information.
Incorporation Date:
March 23, 2006
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Axon Pharma Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
56.36%▲
Total operating revenue
56.27%▲
Operating profit (EBIT)
22.56%▲
EBITDA
23.48%▲
Net Profit (Loss) for the Period
33.17%▲
Total assets
91.09%▲
Total equity
92.37%▲
Operating Profit Margin (ROS)
-4.52%▼
Net Profit Margin
-2%▼
Return on Equity (ROE)
-21.35%▼
Quick Ratio
0.01%▲
Cash Ratio
0.07%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo